School of Medicine

At a transformative moment in our nation’s history, when America’s “Brexit vote” came to pass, where better than Washington University to bring together the thought leaders and experts from disparate fields covering the littered landscape that was, is and forever will be Election 2016?

James G. Miller, the Albert Gordon Hill Professor of Physics in Arts & Sciences, received the 2016 Rayleigh Award at the International Ultrasonics Symposium this fall in Tours, France.

At the Washington University in St. Louis Board of Trustees meeting Oct. 7, several faculty members were appointed with tenure or promoted with tenure.

Epigenome Day will be held Nov. 21 on the Medical Campus, with a full slate of seminars and workshops highlighting epigenomics resources. The free, public event includes a keynote address by Bing Ren of University of California, San Diego.

Researchers at the School of Medicine have developed a new technique to cheaply and rapidly create myriad sets of DNA fragments that detail all possible genetic variants in a particular stretch of DNA. By studying such DNA fragments, scientists can more easily distinguish between genetic variants linked to disease and those that are innocuous.

Researchers at Washington University School of Medicine in St. Louis and Vanderbilt University School of Medicine have identified a human antibody that prevents — in pregnant mice — the fetus from becoming infected with the Zika virus. The antibody also protects adult mice from Zika disease.

Throughout our lives, our brains are always changing. To capture that transformation, scientists will scan the brains of people from kindergarten through their later years to build maps of the brain as it develops and changes over the decades. The endeavor, led by researchers at Washington University, is funded by two grants totaling $34 million from the National Institutes of Health (NIH).

Inflammation is one of the main reasons why people with diabetes experience heart attacks, strokes, kidney problems and other, related complications. Now, in a surprise finding, researchers at the School of Medicine have identified a possible trigger of chronic inflammation.

Researchers at the School of Medicine have developed a chemical compound, named Fluselenamyl, that detects amyloid clumps in Alzheimer’s patients better than current FDA-approved compounds.

Ramakrishna Rao, an associate professor of medicine at Washington University School of Medicine in St. Louis, recently received the 2016 Anne Maurer-Cecchini Award, an honor that recognizes outstanding epidemiological or clinical research on neglected tropical diseases.